SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-18-002433
Filing Date
2018-03-01
Accepted
2018-03-01 07:08:18
Documents
1
Period of Report
2018-02-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4022818shetty_actiniumpharm.html 4  
1 OWNERSHIP DOCUMENT f4022818shetty_actiniumpharm.xml 4 3072
  Complete submission text file 0001213900-18-002433.txt   4507
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Issuer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 643 ZEEDIJK KNOKKE C9 8300
Business Address
Shetty Ajit (Reporting) CIK: 0001667471 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36374 | Film No.: 18654672